Mallinckrodt Files For Chapter 11 Bankruptcy Protection

Company Remains Committed To Generics Separation

After threatening it for some time, Mallinckrodt has initiated Chapter 11 bankruptcy proceedings, succumbing to thousands of claims over its part in the US opioid epidemic.

Bankruptcy Closeup Concept. American Dollars Cash Money,3D rendering. Bankruptcy at Dollar Banknote. Financial USA money banknote Commercial money investment profit concept - Illustration
The bankruptcy filing will help resolve legal liabilities from opioids and CMS matters over Acthar Gel • Source: Shutterstock

Beleaguered Mallinckrodt has filed for Chapter 11 bankruptcy protection in the US, overwhelmed with potential claims stemming from its part in the country’s opioid abuse epidemic and a bill for $650m resulting from the way the company calculated rebates for its best-selling drug, the Acthar Gel (repository corticotropin) injectable.

Bankruptcy proceedings initiated in the US Bankruptcy Court for the District of Delaware are intended to provide for a restructuring...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

  • ADHD

    This is regarding ADHD.

  • GB-Leadership-Free: Article with 150 words (Time to read is < 1 min)

     
    • By 

    In the first cinematic chapter of J.K. Rowling’s wizarding world, young Harry Potter discovers his true identity and enters Hogwarts School of Witchcraft and Wizardry. This enchanting origin story sets the tone for a saga filled with magic, loyalty, and the power of choice.

  • MPP Finds Three More Partners On Key Hepatitis C Treatment

     
    • By 

    The Medicines Patent Pool has entered into a partnership with three companies for glecaprevir/pibrentasvir, a WHO-recommended treatment for people living with hepatitis C. The companies join previous generic licensee Mylan and originator AbbVie.

  • Troubled Teligent Enters Bankruptcy Proceedings As CEO Resigns

     
    • By 

    Teligent is pursuing an asset sale process to “maximize the value of the company” after entering into Chapter 11 bankruptcy proceedings in the US. The firm – which has also seen CEO Tim Sawyer resign – had been struggling of late with remediation issues to address a warning letter at its Buena manufacturing facility in New Jersey, as well as a recent recall.

More from Generics Bulletin